Peer Review reports
From: Adaptive designs were primarily used but inadequately reported in early phase drug trials
| Original Submission | ||
|---|---|---|
| 26 May 2023 | Submitted | Original manuscript |
| 27 May 2023 | Author responded | Author comments - Xin Sun |
| 5 Dec 2023 | Reviewed | Reviewer Report |
| 19 Apr 2024 | Reviewed | Reviewer Report |
| 1 May 2024 | Author responded | Author comments - Xin Sun |
| Resubmission - Version 2 | ||
| 27 May 2023 | Submitted | Manuscript version 2 |
| 8 May 2024 | Author responded | Author comments - Xin Sun |
| Resubmission - Version 3 | ||
| 8 May 2024 | Submitted | Manuscript version 3 |
| 16 May 2024 | Reviewed | Reviewer Report - Edward J Mills |
| 20 May 2024 | Reviewed | Reviewer Report |
| 24 May 2024 | Author responded | Author comments - Xin Sun |
| Resubmission - Version 4 | ||
| 24 May 2024 | Submitted | Manuscript version 4 |
| Publishing | ||
| 27 May 2024 | Editorially accepted | |
| 5 Jun 2024 | Article published | 10.1186/s12874-024-02256-9 |
You can find further information about peer review here.